To accelerate Parkinson's disease (PD) research and connect eligible participants with clinical trials, the Parkinson's Foundation announced the first major milestone of its new PD Trial Navigator ...
Clinical trials are essential for testing the effectiveness of promising new therapies to improve the lives of people with neurofibromatosis. Many people living with NF are interested in advancing ...
GRAND RAPIDS, Mich. (Dec. 10, 2025) — Van Andel Institute and Cure Parkinson’s have renewed a funding agreement to support the International Linked Clinical Trials Program, the world’s largest drug ...